Odd to say the least.
Not long to FDA decision and its been sold down.
Spoke to the guy covering it at Morgan Stanley and the possible takeover of Actavis is not a concern.
Sometimes holders just need to sell.I think thats the case here and the price will quickly recover.
Regards,
on the charge., page-20
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
